2022 |
SpringWorks Therapeutics Inc
|
Independent Director |
538.4 K |
9.5 % |
2022 |
Compass Therapeutics Inc
|
Independent Director |
77.6 K |
72.4 % |
2022 |
SpringWorks Therapeutics Inc
|
Director |
- |
- |
2022 |
Compass Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
Genenta Science SpA - ADR
|
Independent Director |
- |
- |
2021 |
SpringWorks Therapeutics Inc
|
Director |
491.6 K |
-23.6 % |
2021 |
Chemomab Therapeutics Ltd - ADR
|
- |
190 K |
- |
2021 |
Compass Therapeutics Inc
|
Independent Director |
45 K |
- |
2021 |
Chemomab Therapeutics Ltd - ADR
|
Chairman of the Board |
- |
- |
2021 |
Genenta Science SpA - ADR
|
Independent Director |
- |
- |
2021 |
Passage Bio Inc
|
Acting Head of Research & Development and Director |
- |
- |
2020 |
SpringWorks Therapeutics Inc
|
Director and Acting Head of Research and Developme |
643.9 K |
45.0 % |
2020 |
Chemomab Therapeutics Ltd - ADR
|
Chairman of the Board |
- |
- |
2020 |
Genenta Science SpA - ADR
|
Chairman of the Board |
- |
- |
2020 |
Passage Bio Inc
|
Acting Head of Research & Development and Director |
- |
- |
2019 |
SpringWorks Therapeutics Inc
|
Director and Acting Head of Research and Developme |
444.1 K |
344.1 % |
2019 |
Compass Therapeutics Inc
|
Independent Director |
45 K |
- |
2019 |
Passage Bio Inc
|
Acting Head of Research & Development and Director |
- |
- |
2018 |
SpringWorks Therapeutics Inc
|
Director and Acting Head of Research and Developme |
100 K |
- |
2018 |
Arvinas Inc
|
Independent Director |
15.4 K |
-38.2 % |
2017 |
Arvinas Inc
|
Independent Director |
25 K |
- |